Dystonia in Wilson's disease.

Area of Science:

• Neurology
• Neuroimaging
• Movement Disorders

Background:

• Wilson's disease (WD) is a genetic disorder causing copper accumulation.
• Neurologic WD can manifest with various movement disorders, including dystonia.
• Optimized treatment for WD is crucial but may not prevent all complications.

Purpose of the Study:

• To investigate the frequency and characteristics of dystonic movements in patients with neurologic Wilson's disease.
• To identify potential correlations between brain abnormalities on MRI and dystonia in WD patients.
• To explore the relationship between putamen lesions and dystonic symptoms in WD.

Main Methods:

• Studied 27 consecutive patients with neurologic Wilson's disease under optimized treatment.
• Assessed frequency and types of dystonic movements (generalized, segmental, multifocal, focal).
• Utilized magnetic resonance imaging (MRI) to evaluate brain abnormalities, focusing on the putamen.

Main Results:

• Dystonia was observed in 10 out of 27 patients (37%).
• Dystonia presented as a primary symptom in 4 patients and developed later in 6 patients.
• Significantly more frequent putamen lesions were found in dystonic WD patients (80%) compared to non-dystonic WD patients (24%).

Conclusions:

• Dystonia is a common complication in neurologic Wilson's disease, even with optimized treatment.
• Abnormalities in the putamen are strongly associated with the presence of dystonic movements in WD.
• MRI-detected putamen lesions may serve as a biomarker for dystonia risk in Wilson's disease.